RAD21 and acute myeloid leukemia: Three of the seven patients had additional variants detected in the MS compared to the AML including additional FLT3, SETD2, and NF1 mutations in the MS, while two had additional variants of U2AF1 and RAD21 in the AML but not the MS [47].